Surgeons can better anticipate interventions for celiac axis stenosis (CAS) during pancreatoduodenectomy by assessing key preoperative factors.

• Of 1,042 patients, 85 (8.2%) had CAS, but only 11 (1.1%) needed intervention.
• Four preoperative predictors emerged: stenosis diameter ≤2 mm, stenosis rate ≥70%, gastroduodenal-to-common hepatic artery ratio ≥1.0, collateral artery diameter ≥3 mm.
• Interventions were unnecessary when none of these factors were present; all with three or more required action.

These insights can refine preoperative planning and resource allocation during surgery.

A study found that a risk calculator had no significant impact on surgeons’ decisions regarding surveillance for low-risk pancreatic intraductal papillary mucinous neoplasms (IPMNs).

• Clinicians’ estimated likelihood of progression remained unchanged (88% vs. 89% for vignettes).
• Recommendation to continue surveillance did not significantly differ (57% vs. 41% across scenarios).

Surgeons reported varying cancer risk thresholds, indicating a lack of consensus.

• Future research is needed to understand why risk calculators are ineffective in altering decision-making.

Pancreatectomy outcomes for pancreatic neuroendocrine tumors (PNETs) are consistent, regardless of whether they arise from sporadic cases or genetic syndromes like MEN1 and VHL.

• In a study of 1,527 patients, 73 had MEN1, 26 had VHL, and 1,428 exhibited sporadic PNETs.
• Resection rates varied, with R2 resection at 9.6% for MEN1, compared to 2.6% for sporadic and 3.8% for VHL cases.

Despite key differences in demographics and tumor characteristics, postoperative complications and survival rates remained equivalent. This suggests similar patient management strategies may be applied across these groups.